Blue Trust Inc’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Blue Trust Inc’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-185	Closed	-$60.2K	–	3012
2024 Q2	$60.2K	Buy	185 +158	+585%	+$52K	﹤0.01%	1175
2024 Q1	$8.79K	Sell	27 -54	-67%	-$13.3K	﹤0.01%	1478
2023 Q4	$15K	Buy	81 +75	+1,250%	+$14.2K	﹤0.01%	1442
2023 Q3	$2K	Buy	+6	New	+$1.42K	﹤0.01%	1871
2023 Q2	–	Sell	-24	Closed	-$5K	–	2630
2023 Q1	$5K	Sell	24 -1	-4%	-$195	﹤0.01%	1815
2022 Q4	$7K	Buy	25 +24	+2,400%	+$6.07K	﹤0.01%	1649
2022 Q3	$0	Buy	+1	New	+$254	﹤0.01%	2386

Other funds holding SWAV

Ethic Inc New York $6.39B AUM 29.64% 1-Year Est. Return

NRG

Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

Blue Trust Inc's SWAV Position: Q3 2024 in Review

Blue Trust Inc sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2024, closing a stake of 185 shares — an estimated $60.2K sold.

Blue Trust Inc first reported a position in SWAV in Q3 2022 and held it in 7 quarters. The position peaked at $60.2K in Q2 2024. 2 funds tracked by Wall St. Rank hold SWAV as of Q3 2024.

Blue Trust Inc reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Blue Trust Inc sold 185 Shockwave Medical, Inc. Common Stock shares in Q3 2024, an estimated $60.2K.
Blue Trust Inc first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
Blue Trust Inc's Shockwave Medical, Inc. Common Stock position peaked at $60.2K in Q2 2024.
2 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2024.

Based on Blue Trust Inc's 13F filing for Q3 2024, filed 17 Oct 2024.